Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01)
| קרן | National Institute of Diabetes and Digestive and Kidney Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 20/10/2021 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | This grant encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell therapies for type 1 diabetes (T1D).
Funding: $500,000 per year Duration: 5 years
Research Authority due date: 10.9.21 LOI (encouraged) due date: 20.9.21 Full proposal due date: 20.10.21
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 08/04/2021 |
